Incyte Clinical Portfolio To Be Featured In 23 Abstract Presentations At The 2015 ASCO And European Hematology Association Annual Meetings

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) today announced that 23 abstracts detailing studies from its clinical development pipeline, including those conducted by Incyte, Novartis and independent investigators, will be presented at the 2015 American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) annual meetings. These conferences will take place from May 29th – June 2nd (ASCO) in Chicago, IL and June 11th – 14th (EHA) in Vienna, Austria.

Help employers find you! Check out all the jobs and post your resume.